Xylazine now isn’t detailed like a managed material, that means the Drug Enforcement Company doesn’t have a transparent way to regulate it. Members of Congress in both equally chambers have launched laws to classify xylazine like a Schedule III substance.Using the rising risk designation, the Business office of National Drug Handle Policy (ONDC